Erasca, Inc. (ERAS)
10.20
-0.45
(-4.23%)
USD |
NASDAQ |
May 01, 14:57
Erasca Shareholders Equity (Quarterly) : 325.17M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | 346.18M |
| Incyte Corp. | 5.623B |
| Tonix Pharmaceuticals Holding Corp. | 245.15M |
| Karyopharm Therapeutics, Inc. | -292.93M |
| Syndax Pharmaceuticals, Inc. | 64.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 407.46M |
| Total Liabilities (Quarterly) | 82.28M |
| Debt to Equity Ratio | 0.145 |
| Current Ratio | 10.04 |
| Net Debt Paydown Yield | 0.11% |